Case Management of Suspect Avian Influenza A (H5N1) Virus Infection in Humans Part 1: Background information on clinical features of human infection with.

Slides:



Advertisements
Similar presentations
C E N T R A L P I E D M O N T C O M M U N I T Y C O L L E G E Pandemic and Influenza: A Guide to Understanding.
Advertisements

Prepared by Dr Alissar Rady, WHO Lebanon
Swine flu.
1 Avian Influenza Bird Flu H5N1. 2 Avian Influenza… Is a respiratory illness in birds Wild birds and ducks are the natural reservoir for infection, though.
SEVERE ACUTE RESPIRATORY SYNDROME (SARS) Quek Boon Har UMMC.
Dr S Aboobakar Regional Public Health Superintendent.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
Swine Influenza April 30, 2009 Bill Mason, MD Jill Hoffman, MD Dawn England, MPH.
NH Department of Health and Human Services Division of Public Health Services Influenza Seasonal and H1N1 Patricia Ingraham, MPH Communicable Disease Control.
M. A. El-Farrash. Recommendations to prevent infection by the H1N1 virus consist of the standard personal precautions against influenza. This includes.
Laboratory Diagnostics and Specimen Collection. Learning Objectives Know the basic components of specimen collection kits for use with suspect avian influenza.
MERS-CoV: Reporting and Laboratory Testing Republic of Lebanon Ministry of Public Health Epidemiological Surveillance Program May 2014.
Swine Influenza (pig flu) is a respiratory disease of pigs caused by type A influenza virus that regularly causes outbreaks of influenza in pigs. Swine.
H1N1.
Treatment Recommendations of swine flu By Nesrien Mohammed Shalabi Ass. Prof of Thoracic Medicine 5/5/2009.
INTEGRIS Preparedness Plan: Ebola Virus Disease (EVD) With the spread of Ebola to the U.S., ensuring our employees and communities are safe is the utmost.
EBOLA Virus Disease August 22, What is Ebola Virus Disease (EVD)? Ebola virus disease (also known as Ebola hemorrhagic fever) is a severe, often-fatal.
Raman Jwad. What is bird flu. Overview  H5N1 is also the most common form of bird flu. Not only is it deadly to birds, but it can easily affect humans.
About Swine Flu Dr.Kedar Karki. What is Swine Influenza? Swine Influenza (swine flu) is a respiratory disease of pigs caused by type A influenza virus.
Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus
1 Case Management of Suspect Human Avian Influenza Infection Part 1: Background information on clinical features and management of avian influenza.
H ₁N₁ What you Need to Know Q & A Session Ozark’s Technical Community College Michelle Howard, RN, BSN.
Case Study Module 4 Part 2 Patient Management
SWINE FLU.
By: Sharee Windish, Haley Bradley & Jordan North
Swine Influenza Update (Swine flu)
Swine Flu update Jacob Kool Communicable Disease Surveillance and Response WHO South Pacific 29 April 2009 WHO/WPRO.
Health Care Personnel Influenza Vaccination [ORGANIZATION NAME] [ORGANIZATION LOGO]
20 Answers About Influenza
Severe Acute Respiratory Syndrome (SARS) Michael Leonard.
Module 4: Case Management of Suspect Human Avian Influenza Infection; Parts 1 & 2 Management of Suspect Cases of Human Infection with Avian Influenza.
Case Management of Suspect Human Avian Influenza Infection
Pandemic Influenza. Guidance for Pandemic Influenza: Infection Control in Hospitals and Primary Care Settings UK Pandemic Influenza Contingency Plan Operational.
TANEY COUNTY HEALTH DEPARTMENT AUGUST 2009 Situation Update: H1N1 Influenza A.
1 Case Management of Suspect Human Avian Influenza Infection Part 3: Triage of Suspected Avian Influenza Cases.
سورة البقرة ( ۳۲ ). Influenza is a serious respiratory illness which can be debilitating and causes complications that lead to hospitalization and.
H1N1 VIRUS SWINE FLU. What is the H1N1 Virus? It is a new virus that is spread from person to person first detected in people in the United States in.
Swine Influenza Information. Update as of 4/28/09 As of 11:00 AM there have been 64 cases reported in the USA. There has not been a confirmed case in.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
Avian Influenza "bird flu" Contagious disease of animals caused by viruses that normally infect only birds and pigs H5N1 can infect people (very rarely)
SARS: Protecting Workers. OSHA Guidance for Employers on Severe Acute Respiratory Syndrome (SARS) Potentially deadly respiratory disease Potentially deadly.
Influenza Surveillance Danae Bixler, MD, MPH Infectious Disease Epidemiology Program.
Clinical Aspects of Severe Acute Respiratory Syndrome (SARS), 2003 John A. Jernigan, MD, MS For the SARS Clinical/Infection Control Investigative Team.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
SARS. What is SARS? Severe Acute Respiratory Syndrome Respiratory illness Asia, North America, and Europe Previously unrecognized coronavirus.
How SARS Works. Originally, the World Health Organization (WHO) defined severe acute respiratory syndrome (SARS) as an "atypical pneumonia of unknown.
Case Management of Suspect Avian Influenza A (H5N1) Virus Infection in Humans May, 2007.
Avian Influenza H5N1 Prepared by: Samia ALhabardi.
Confidentiality level: Version: 1.0 Confidentiality level: Version: 1.0 Protect yourself from Swine Flu.
Severe acute respiratory syndrome. SARS. SARS is a communicable viral disease caused by a new strain of coronavirus. The most common symptoms in patient.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
Swine Flu Dr Anil Ballani Consultant Physician Hinduja & Lilavati Hospital.
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
CURRENT HEALTH PROBLEM AVIAN BIRD FLU presented by: Rajeev bin Shamsuddin Perisamy Ting Sie Ong.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
SWINE INFLUENZA. What is Swine Influenza? What is Swine Influenza? Swine Influenza (swine flu) is a respiratory disease of pigs caused by type A influenza.
H1N1 information Dr Sangeeta Joshi Consultant Microbiologist Manipal Hospital Bangalore.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Agilent Restricted Influenza H1N1 A (Swine Influenza) Information for Agilent’s Employees.
Influenza A, H1N1 “Swine Flu” The Facts and How to Protect Yourself.
Influenza A (H1N1). What is Influenza A (H1N1)? Influenza A(H1N1) is caused by a novel virus that resulted from the reassortment of 4 viruses from pigs,
Screening & Investigation of Suspect Avian Influenza (H5N1) By Akrum Hamdy.
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Qun Li, M.D., Lei Zhou, M.D., Minghao Zhou, Ph.D., Zhiping Chen, M.D., Furong.
Seasonal Influenza and Pandemic Influenza A (H1N1, H5N1) Virus Dr. Alaa kuttar musa Department of Medicine College of Medicine/ Basra University.
Preparing for Pandemic Influenza: A Primer for EMS Personnel
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
Avian Influenza A (H5N1) “Bird Flu”
Influenza Presentation for Health Care Workers
Avian influenza ( Bird flu )
Presentation transcript:

Case Management of Suspect Avian Influenza A (H5N1) Virus Infection in Humans Part 1: Background information on clinical features of human infection with avian influenza A (H5N1) viruses May, 2007

Learning Objectives Recognize clinical features of avian Influenza A (H5N1) virus infection in humans Understand how information about the patient before onset of illness can help you suspect H5N1 virus infection

Part 1 Session Outline Clinical features Epidemiological Context –Exposure

Illness Scenario Alex sick for three days –Fever –Headache –Cough –Shortness of breath –Muscle aches –Watery diarrhea No one else sick Works at poultry farm and handles poultry Question: Is avian Influenza A (H5N1) the most likely cause of Alex’s symptoms?

Clinical Features

General Information Human influenza Avian Influenza A (H5N1) Affected Age Groups All ages affected Highest attack rate in children <5 years Most complications in elderly >65 years and persons with chronic medical conditions Children of all ages Healthy young adults Highest CFR in adolescents. Estimated Incubation Period Mean: 2 days Range: 1 – 4 days Mean: 2 – 5 days ≤7 days

Signs and Symptoms Avian Influenza A (H5N1) Type of infectionLower respiratory SymptomsFever, Cough, Headache Shortness of breath, difficulty breathing Diarrhea in some cases Hospitalized PatientsPneumonia Hypoxia requiring oxygen and respiratory failure requiring intubation and mechanical ventilation Acute Respiratory Distress Syndrome (ARDS)

Laboratory Findings Commonly associated with human infection with avian influenza A (H5N1) viruses: –Drop in white blood cell count (leukopenia) Drop in lymphocytes, a kind of white blood cells (lymphopenia) –Mild to moderate drop in blood platelet count –Increased aminotransferases (liver enzymes)

Unusual Clinical Manifestations and Outcomes Knowledge of avian influenza A (H5N1) virus infection in humans is still evolving Unusual symptoms –Southern Vietnam – encephalitis and diarrhea –Fever and diarrhea can be the only early signs and symptoms before pneumonia occurs later with H5N1 virus infection

Complications Seasonal Influenza Ear infections, sinusitis Bronchitis, bronchiolitis Pneumonia –viral or secondary bacterial Exacerbation of chronic conditions Muscle inflammation Neurologic Disease –Seizures –Encephalopathy and encephalitis –Reye syndrome H5N1 Virus Infection in Humans Most cases develop pneumonia Acute Respiratory Distress Syndrome (ARDS) Multiorgan failure Encephalitis Cytokine storm

Alex Question: Do you think Alex has signs and symptoms of H5N1? Why or why not?

Epidemiological Context

Exposure to Avian Influenza (H5N1) Virus 1.Infected poultry, particularly coming in contact with respiratory secretions 2.Infected wild or pet birds 3.Other infected animals (e.g., pigs, cats, dogs) 4.Wild bird feces, poultry manure and litter containing high concentrations of virus 5.Fecally contaminated surfaces

H5N1 Virus Exposures Continued 6.Under- or uncooked poultry meat or eggs from infected birds 7.Contaminated vehicles, equipment, clothing, and footwear at affected sites, such as poultry farms with outbreaks 8.Contaminated air space (e.g., a barn, hen-house, or the air space proximal to barn exhaust fans) 9.Bodies of water with infected bird carcasses 10. Close contact with (within 3 feet of) confirmed human cases

Local Customs - Unique Exposures Cock fighting Swan defeathering Playing with dead chickens Duck blood pudding, local customs Hunting practices

Alex Question: Do you think Alex could have been exposed to highly pathogenic avian influenza A (H5N1) virus?

Using All of The Information

Alex’s Situation 24 year old Alex sick for three days –Fever –Headache –Cough –Shortness of breath –Muscle aches –Watery diarrhea No one else sick Alex works on poultry farm where he handles poultry

Alex Question: Would you suspect avian influenza A (H5N1) virus infection? Why or why not?

Part 1 Summary Individuals with avian influenza A (H5N1) virus infection may have non- specific lower respiratory symptoms, or (rarely) none at all Ask about recent exposure and contact with humans or animals that may have had avian influenza A (H5N1) virus infection

Case Management of Suspect Avian Influenza A (H5N1) Virus Infection in Humans Part 2: Case Management of Suspected Human Cases of Avian Influenza A (H5N1) Virus Infection

Learning Objectives Testing available for diagnosing –Clinical specimens Current treatment options Infection control measures

Part 2 Session Overview Laboratory Testing Treating Suspected Patients Infection Control in the Healthcare Setting

Laboratory Testing

Diagnostics Avian Influenza A (H5N1) Virus –Specimens for testing Influenza A Imaging

Avian Influenza A (H5N1) Virus Laboratory Tests RT-PCR –Detects viral RNA –Diagnose H5N1 in humans –BSL-2 conditions –Results within hours Viral culture –Only in enhanced BSL-3 laboratory –Results in 2-10 days Serologic Testing –Rise in H5N1 specific antibodies –Testing only in enhanced BSL-3 laboratory

Clinical Specimens for Detecting Avian Influenza A (H5N1) Lower Respiratory Tract* –Broncheoalveolar lavage fluid –Endotracheal aspirate –Pleural fluid –Sputum Upper Respiratory Tract –Oropharyngeal swabs* –Nasal Swab Collect multiple specimens from the same suspect H5N1 patient on different days for RT- PCR testing * Preferred specimens

Clinical Specimens for Testing Serology –Acute and convalescent serum specimens Acute collected within 1 week of symptom onset Convalescent collected 2-4 weeks after symptom onset –Other infections or concurrent illness Collect all possible specimens, serial collection

Clinical Specimens for Testing Autopsy Specimens –Eight blocks or fixed-tissue specimens from each of the following sites Central (hilar) lung with segmental bronchi Right and left primary bronchi Trachea (proximal and distal) Pulmonary parenchyma from both right and left lung –Major organs Myocardium (right and left ventricle) CNS (cerebral cortex, basal ganglia, pons, medulla, and cerebellum) Organ with significant gross or microscopic pathology)

Rapid Influenza Diagnostic Tests NOT RECOMMENDED TO DETECT AND DIAGNOSE H5N1 VIRUS INFECTION –Many commercial kits available –Results in minutes –Low sensitivity (FALSE NEGATIVES LIKELY) –Positive result cannot differentiate seasonal influenza A from avian influenza A (H5N1) virus infection –Negative result does not rule out avian influenza A (H5N1) virus infection as diagnosis

Laboratory Diagnostics CDC’s influenza laboratory is nation’s influenza reference laboratory Capable of performing additional tests –Immunohistochemical testing on autopsy specimens CDC’s Emergency Response Hotline –

Imaging Chest X-ray changes of pneumonia are common in the lungs of H5N1 patients Non-specific changes Diffuse or patchy infiltrates Fluid in the space surrounding the lungs Cavities forming in the lung tissue BBC News. Saturday, 3 December 2005

Avian Influenza A (H5N1) Virus Patient’s Chest X-Rays Chest x-ray of a patient with avian influenza A (H5N1) virus infection, shown by day of illness Day 5 Day 7 Day 10 Tran Tinh Hien, Nguyen Thanh Liem, Nguyen Thi Dung, et al. New England Journal of Medicine. 18 March, vol. 350 no. 12. pp

Treating Suspected Cases

Treatment Options Antivirals Supportive care

Neuraminidase Inhibitors Two drugs available –Oseltamivir (Tamiflu®) and Zanamivir (Relenza ®) –Should be given as soon as possible –Effective for treatment and prevention –Used for seasonal influenza and infection with avian influenza A (H5N1) viruses

Oseltamivir Dosage for seasonal influenza Adults: 75 mg twice a day for 5 days Children: <1 year, not recommended If < 15 kg: the dose should be 30 mg twice a day for 5 days If >15 kg to <23 kg: the dose should be 45 mg twice a day for 5 days If >23 kg to <40 kg: the dose should be 60 mg twice a day for 5 days If >40 kg: the dose should be 75 mg twice a day for 5 days

Oseltamivir Treatment for H5N1 patients Best dosage for H5N1 patients unknown –Consider longer treatment (7 to 10 days) OR –Higher doses (150 mg) –Begin as soon as possible Dosage for prevention –Once daily for 7 to 10 days after last exposure Side Effects –Nausea and vomiting –Skin rash –Neurological problems

Oseltamivir Effectiveness in seasonal influenza –Reduces influenza symptoms by 1 day –Reduces some complications of influenza Cautions- Consider Risk versus Benefits –People with kidney disease (adjust dose) –Pregnant or nursing females Contraindication –<1 year of age –Hypersensitivity to any component of product Resistance –Detected in some H5N1 patients

Zanamivir Inhaled by mouth via special device May be used for treatment of influenza >7 years of age Treatment dosage –Once in morning and night, 5 days Side effects –Wheezing, and breathing problems

Zanamivir Effectiveness in seasonal influenza –Reduces influenza symptoms by one day –Reduces lower respiratory tract complications Consider Risk vs. Benefit –People with chronic respiratory disease –Pregnant or nursing females Resistance –Very rare in human cases of avian influenza A (H5N1) virus infections –Active against Oseltamivir resistant H5N1 viruses

Other Treatments? Amantadine and Rimantadine –Some H5N1 viruses are resistant Corticosteroids –Not recommended –Only for worsening sepsis with adrenal insufficiency

Treating Children Different Oseltamivir dosage –Based on child’s weight –Not approved in children <1 year No aspirin for children <18 years of age –Use Acetaminophen or Ibuprofen Children potentially infectious for longer periods than adults –If child cannot remain hospitalized, educate family about infection control –Source: WHO Writing Group, Emerging Infectious Diseases, Vol. 12, No. 1, January 2006.

Antibiotics Broad-spectrum –Do not use as a prophylactic –Give empiric therapy for suspected bacterial pneumonia Secondary bacterial infection therapy –Treat with intravenous antibiotics as recommended

Supportive Care Hospital care for suspected or confirmed avian influenza A (H5N1) cases should include: Isolating the patient Supplemental oxygen and ventilation Intensive care support for organ failure

Infection Control in Health Care Setting

Infection Control Measures Patients hospitalized for clinical monitoring, diagnostic testing, and antiviral therapy Droplet/airborne precautions –Isolation –N95 respirators or more protective Eye protection (within 3 feet) –Goggles or face shields

Infection Control Measures Standard Precautions –Hand washing before and after contact with patient or potentially contaminated items Contact Precautions –Gloves and gown worn –Dedicated equipment used CDC recommendations t-control.htm t-control.htm

Managing Corpses No known risk of transmission from dead bodies Autopsy procedures could result in transmission –Use appropriate protective equipment You should know –Where corpses may be sent for disposal –Cultural or religious beliefs to respect when handling corpses

Part 2 Summary 1.Important appropriate clinical specimens are collected and tested 2.Begin treatment with neuraminidase inhibitor (oseltamivir) immediately! Do not wait!

Case Management of Suspect Avian Influenza A (H5N1) Virus Infection in Humans Part 3: Public Health Action

Learning Objectives Understand case management from public health perspective Recognize opportunities for public health authorities to effectively communicate avian influenza A (H5N1) information

Part 3 Session Overview 1.Collect Case Information Classify case according to case definition for surveillance 2.Facilitate specimen collection and laboratory testing 3.Information on avian influenza A (H5N1) illness 4.Infection control measures in the home 5.Active case follow up 6.Identify close contacts and recommend antiviral chemoprophylaxis (oseltamivir) 7.Enhance surveillance

Pandemic Influenza Plan Know your role and responsibilities as outlined in your health department’s plan Identify key collaborators before and during investigation

Collecting Case Information

Case Information Name and contact Information Unique Identifier Occupation (address) Demographic Symptoms Test Results Treatment Outcome Travel history Potential exposures Close contacts Name of person reporting Healthcare facility name and location Patient information:

Updated Interim Guidance for Laboratory Testing of Persons with Suspected Infection with Avian Influenza A (H5N1) Virus in the United States Testing for avian influenza A (H5N1) virus infection is recommended for a patient who has an illness that: requires hospitalization or is fatal; AND has or had a documented temperature of ≥100.4° F; AND has radiographically confirmed pneumonia, acute respiratory distress syndrome (ARDS), or other severe respiratory illness for which an alternate diagnosis has not been established; AND has at least one of the following potential exposures within 10 days of symptom onset:

A) History of travel to a country with influenza H5N1 documented in poultry, wild birds, and/or humans, AND had at least one of the following potential exposures during travel: direct contact with (e.g., touching) sick or dead domestic poultry; direct contact with surfaces contaminated with poultry feces; consumption of raw or incompletely cooked poultry or poultry products; direct contact with sick or dead wild birds suspected or confirmed to have influenza H5N1; close contact (approach within 1 meter [approx. 3 feet]) of a person who was hospitalized or died due to a severe unexplained respiratory illness;

B) Close contact (approach within 1 meter [approx. 3 feet]) of an ill patient who was confirmed or suspected to have H5N1; or C) Worked with live influenza H5N1 virus in a laboratory.

Case by Case Considerations! Mild or atypical disease (hospitalized or ambulatory) with one of the exposures listed above Severe or fatal respiratory disease whose epidemiological information is uncertain, unavailable, or otherwise suspicious but does not meet the criteria above

Proposed Influenza Division/CDC Case Definitions Confirmed Suspect Report under investigation Non-case To be used for reporting purposes A separate CDC Health Alert Network was released that includes criteria for who should be tested for Influenza A (H5N1)

Confirmed Case (symptoms, exposure, laboratory confirmation) –Documented temperature >38 C (>100.4 F) and one of the following: cough, sore throat, and/or respiratory distress AND –One of the following exposures within 10 days of onset Direct exposure to sick or dead domestic poultry Direct exposure to surfaces contaminated with poultry feces Consumption of raw or partially cooked poultry or poultry products Close contact (within 3 feet) of an ill patient with confirmed or suspected avian influenza A (H5N1) infection Works with live HPAI (H5N1) virus in a laboratory AND… Proposed Influenza Division/CDC Case Definitions

Confirmed Case (Continued) –Positive for avian influenza A (H5N1) virus by one of the following methods Isolation of H5N1 from viral culture Positive RT-PCR for H5N1 4 fold rise in H5N1 specific antibody titer by microneutralization assay in paired sera Positive IFA for H5 antigen using H5N1 monoclonal antibodies Proposed Influenza Division/CDC Case Definitions

Suspect Case –Documented temperature >38 C (>100.4 F) and one of the following: cough, sore throat, and/or respiratory distress AND –One of the following exposures within 10 days of onset Direct exposure to sick or dead domestic poultry Direct exposure to surfaces contaminated with poultry feces Consumption of raw or partially cooked poultry or poultry products Close contact (within 3 feet) of an ill patient with confirmed or suspected avian influenza A (H5N1) virus infection Works with live HPAI (H5N1) virus in a laboratory –Laboratory test for avian influenza A (H5N1) is pending, inadequate or unavailable Proposed Influenza Division/CDC Case Definitions

Report Under Investigation –Additional information needed on clinical and exposure information Not a Case –Negative avian influenza A (H5N1) virus testing result from a sensitive laboratory testing method using adequate and appropriately timed clinical specimens Proposed Influenza Division/CDC Case Definitions

Reporting Report through normal channels Information shared with WHO— probable and confirmed cases according to WHO case definition Help determine pandemic phase in US Local PH State PH CDC

Facilitate Specimen Collection and Laboratory Testing

Specimen Collection Best specimens –Lower respiratory tract Broncheoalveolar lavage fluid Endotracheal aspirate Pleural fluid –Upper respiratory tract Oropharyngeal swabs Have supplies stocked for timely collection of appropriate specimens

Laboratory Testing Be familiar with testing available in your area Know which laboratories can perform which tests Know tests available at CDC

Provide Information on Avian Influenza A (H5N1) Illness

Avian Influenza A (H5N1) Virus Infection Emerging disease with evolving knowledge Empathy with public concerns Provide consistent and up to date literature to healthcare providers –Appropriate reading level –Translation for non-English speaking community members Information such as clinical features, exposure, and treatment options

Educate on Infection Control Measures in the Home

Infection Control Measures Give consistent and up to date literature to healthcare providers Hand washing –Soap and water for seconds –Alcohol based sanitizer, >60% alcohol Limit close contact with patient CDC Guidance on Community Mask Use During a Pandemic.

Infection Control Measures Seek medical care if condition worsens Stay home for 24 hours after symptoms resolve CDC’s recommendation for in- home isolation – ance/i/pdf/i.pdfhttp:// ance/i/pdf/i.pdf

Conduct Active Case Follow Up

Active Follow Up Reasons for follow up –Specimens for testing –Timely notification of results –Monitor delivery of antiviral therapy –Secure antivirals if shortage –Note unusual clinical presentations or complications Follow up by telephone –Patient –Healthcare provider (when available) –Surrogate (e.g. spouse)

Identify Close Contacts

Definition of Close Contacts The definition of close contact is household and other contacts in work, school, and community settings who had close unprotected (i.e., not wearing PPE) contact in the 1 day before through 14 days after the case patient’s symptom onset. Examples of close contact (within 1 meter) with a person include providing care, speaking with, or touching. * enza/WHO_CDS_EPR_GIP_2006_4r1.pdf * Depending on the specific circumstances suspect or confirmed cases that have completed isolation for at least 7 days, and who are no longer symptomatic, may not be considered a source of exposure to others.

Identifying Close Contacts List of contacts from patient’s case report form Close contact = within 3 feet or 1 meter –Sharing utensils, close conversation, direct contact Follow Up –Characterize exposure –Identify signs and symptoms Those with symptoms treated as potential case of infection with avian Influenza A (H5N1) virus

Recommendations to Contacts No symptoms Post-exposure prophylaxis for close contacts of a strongly suspected or confirmed human case of avian influenza A (H5N1) virus infection –WHO “high” and “moderate” risk categories, poultry depopulators, and responders who have been on infected premises should receive post exposure prophylaxis

Instruction to Contacts No symptoms (continued) Self monitor for 10 days after last exposure –Fever, respiratory symptoms, diarrhea, and/or conjunctivitis –Seek medical care if symptoms present –Notify public health authorities Follow infection control measures in the home

Enhance Surveillance

Enhance Surveillance during an Animal or Human Outbreak of Avian Influenza A (H5N1) Virus Infections Active case finding among occupationally exposed Sensitization of community to report illness Expand SARI and/or ILI surveillance to local hospitals, private practice etc... –Screening in hospitals Training on procedures and reporting Door-to-door community surveillance Telephone hotlines for reporting

Part 3 Summary Public health authorities serve as protectors of their community’s health Important that public health authorities provide clear and consistent messages to patients and contacts Case management also means identifying contacts

Glossary Avian Influenza A Viruses Influenza A viruses that cause infection of wild birds and poultry. Contraindication A specific circumstance when the use of a certain treatment could be harmful. Seasonal Influenza Expected rise in influenza occurrence among humans living in temperate climates; occurs during the winter season with strains of human influenza viruses that have minor changes from season to season.

References and Resources CDC Guidance for State and Local Health Departments for Conducting Investigations of Human Illness Associated with Domestic Highly pathogenic Avian Influenza Outbreaks in Animals (Draft). Preliminary clinical and epidemiological description of influenza A (H5N1) in Viet Nam. 12 February dex.html dex.html Tran Tinh Hien, et al. Avian Influenza A (H5N1) in 10 Patients in Vietnam. N Engl J Med March 18, 2004: 350(12), p WHO interim guidelines on clinical management of humans infected by influenza A(H5N1), 2 March dex.html dex.html WHO pandemic influenza draft protocol for rapid response and containment. Updated draft 30 May a.pdf 6a.pdf